Tickers

Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report

Nov 5, 2026 12:23 AM · Investing

Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report


Original source: Investing